𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vivo biostability of polysiloxane polyether polyurethanes: Resistance to metal ion oxidation

✍ Scribed by Bob Ward; James Anderson; Mike Ebert; Rick McVenes; Ken Stokes

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
597 KB
Volume
77A
Category
Article
ISSN
1549-3296

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Polyether polyurethanes are subject to oxidation catalyzed by and through direct (redox) reaction with transition metal ions (cobalt), released by corrosion of metallic parts in an implanted device. Replacing part of the polyether with polysiloxane appears to reduce susceptibility to metal ion oxidation (MIO). In vitro studies indicated that polyurethanes containing 20–35% polysiloxane (PS‐20 and PS‐35) are about optimum. We implanted tubing samples containing cobalt mandrels in the subcutis of rabbits for periods up to 2 years. After 2 years, only traces of microscopic cracks were seen on half the PS‐35 samples, PS‐20 significantly delayed MIO, while the polysiloxane‐free control was very severely degraded. Infrared spectroscopy established that polyether soft segment oxidation was occurring in PS‐20. We could not directly evaluate oxidation in PS‐35 because siloxane bands mask the aliphatic ether. Indirect FTIR evidence suggests that there is very slight polyether oxidation that develops early, and then seems to stabilize. The molecular weight of degraded PS‐20 decreased. That of microcracked PS‐35 decreased negligibly while that of undamaged PS‐35 increased slightly after 2‐year in vivo. The polysiloxane‐free control was profoundly degraded. PS‐20 has much improved MIO resistance, while that for PS‐35 is highly MIO resistant compared with its polysiloxane‐free control. © 2006 Wiley Periodicals, Inc. J Biomed Mater Res, 2006

📜 SIMILAR VOLUMES

In vivo biostability of polysiloxane pol
In vivo biostability of polysiloxane polyether polyurethanes: Resistance to biologic oxidation and stress cracking
✍ Robert Ward; James Anderson; Rick McVenes; Ken Stokes 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

## Abstract Polyether polyurethanes are extremely interesting for use in implantable devices. They are, however, susceptible to autoxidative degradation and stress cracking. One approach to improving biostability is to replace some of the polyether with polysiloxane. Shore 80A polyether polyurethan

In vivo biostability of polyether polyur
In vivo biostability of polyether polyurethanes with fluoropolymer and polyethylene oxide surface modifying endgroups; resistance to metal ion oxidation
✍ Robert Ward; James Anderson; Rick McVenes; Ken Stokes 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

## Abstract Polyether polyurethanes are subject to oxidation catalyzed by, and through direct (redox) reaction with transition metal ions (metal ion oxidation, MIO). The source of the ions is corrosion of metallic parts within an implanted device. A Shore 80A polyether polyurethane was modified wit

In vivo biostability of polyether polyur
In vivo biostability of polyether polyurethanes with fluoropolymer surface modifying endgroups: Resistance to biologic oxidation and stress cracking
✍ Bob Ward; James Anderson; Rick McVenes; Ken Stokes 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

## Abstract A series of Shore 80A polyether polyurethanes were synthesized with from 0 to 6% fluoropolymer surface modifying endgroups (SME) to provide the bulk properties of the polyurethane with the surface properties of the fluoropolymer. It was theorized that the fluoropolymer would migrate to

In vivo biostability of polyether polyur
In vivo biostability of polyether polyurethanes with polyethylene oxide surface-modifying end groups; resistance to biologic oxidation and stress cracking
✍ Mike Ebert; Bob Ward; James Anderson; Rick McVenes; Ken Stokes 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB

## Abstract Polyethylene oxide (PEO) on polymer surfaces has been reported to reduce cellular adhesion, a very desirable property for cardiac pacing leads. A Shore 80A polyether polyurethane with up to 6% PEO surface‐modifying end groups (SME) was evaluated for its chronic __in vivo__ biostability.